25 Nov

Results of Meeting

ASX Announcement – 25 November 2021 Resonance Health Ltd ABN: 96 006 762 492 141 Burswood Road, Burswood, WA 6100, AUSTRALIA Postal: PO Box 71, Burswood, WA 6100, AUSTRALIA www.resonancehealth.com T + 61 8 9286 5300 info@resonancehealth.com RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS In accordance with Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act 2001 (Cth), Resonance Health Ltd (ASX: RHT) ( Resonance Health or Company ) provides the results of the 2021 Annual General Meeting ( AGM ) held earlier today, which are set out in the attached schedule together with the details of the proxy votes and votes cast in respect of each resolution. All resolutions put to the AGM were decided by a poll. Enquiries: Nick Allan – Company Secretary E: nicka@resonancehealth.com P: +61 (0)8 9286 5300 This announcement has been authorised for release in accordance with the delegated authority of the Board of Directors of Resonance Health Limited. About Resonance Health Resonance Health is an Australian healthcare technology and services company, specialising in the development and delivery of non-invasive medical imaging software and services. The Company’s products are used globally by clinicians in the diagnosis and management of human diseases and by pharmaceutical and therapeutic companies in their clinical trials. Resonance Health has gained endorsement by leading physicians worldwide for consistently providing high quality quantitative measurements essential in the management of diseases. Resonance Health’s dedication to scientific rigour and quality management has enabled it to achieve regulatory clearances for a range of Software as a Medical Device ( SaMD ) products in the USA, Europe, and Australia and to proudly carry ISO 13485 certification for the design and manufacture of medical devices. A number of these SaMD products incorporate the use of Artificial Intelligence ( AI ): ? FerriScan® - provides an accurate measurement of liver iron concentration ( LIC ) through a non-invasive MRI-based technology, for use in the assessment of individuals with iron overload conditions. FerriScan is internationally recognised as the gold standard in LIC assessment ? FerriSmart® - an AI-driven system for the automated real-time measurement of LIC in patients using non-invasive MRI-based technology ? HepaFat-Scan® - an MRI-based solution which provides a reliable non-invasive measure of liver fat in liver tissue for use in the assessment of individuals with confirmed or suspected fatty liver disease ? HepaFat-AI® - an AI-driven system for the automated real-time multi-metric measurement of liver fat in patients using non-invasive MRI-based technology The Company has an active development pipeline of additional medical imaging analysis products and services, including LiverSmart™ , which combines FerriSmart® and HepaFat-AI® into a single multi-parametric MRI session and Alert-PE™ , an AI tool for the automated revie of chest CT scans of patients with suspected pulmonary embolism. 2 | P a g e RESONANCE HEALTH LTD ANNUAL GENERAL MEETING Thursday, 25 November 2021 Results of Meeting For Against Proxy's Discretion Abstain* For Against Abstain* 64,608,916 237,682 112,169 0 70,154,948 237,682 0 99.5% 0.4% 0.2% 99.7% 0.3% 145,931,396 41,911 246,487 0 151,611,746 41,911 0 99.8% 0.0% 0.2% 100.0% 0.0% 145,378,111 530,066 196,487 115,130 151,008,461 530,066 115,130 99.5% 0.4% 0.1% 99.7% 0.3% 59,588,029 5,073,558 183,485 113,695 65,205,377 5,073,558 113,695 91.9% 7.8% 0.3% 92.8% 7.2% * Vote s ca s t by a pe rs on who a bs ta i ns on a n i te m a re not counte d i n ca l cul a ti ng the re qui re d ma jori ty on a pol l . Adopti on of the Re s ona nce Long Te rm Ince nti ve Pl a n 4 Resolution Result Instructions given to validly appointed proxies (as at proxy close) Number of votes cast on the poll (where applicable) Resolution Resolution Details Resolution Type Ca rri e d Ordi na ry Ca rri e d Ca rri e d Ca rri e d 5 Approva l Of Addi ti ona l 10% Pl a cement Fa ci l i ty Speci a l Ordi na ry Ordi na ry 1 Adopti on Of Re mune ra ti on Re port 2 Re-El ecti on of Mr Si mon Pa nton a s a Di rector

More from Resonance Health

Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Resonance Health (ASX:RHT) when you join Listcorp.